Realizing individualized cancer treatment through patient genome sequencing

Recent Publications

Osako, T., Iwase, T., Ushijima, M., Yonekura, R., Ohno, S. and Akiyama, F.
A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients.
Br. J. Cancer., in press (2017)
Takemoto, A., Miyata, K. and Fujita, N.
Platelet-activating factor podoplanin: from discovery to drug development.
Cancer and metastasis reviews, 36, 225-234 (2017)
Katayama, R.
Therapeutic strategies and mechanisms of drug resistance in Anaplastic Lymphoma Kinase (ALK)-rearranged lung cancer.
Pharmacol. Ther., 117, 1-8 (2017)
Fuse, J. M., Okada, K., Oh-hara, T., Ogura, H., Fujita, N. and Katayama, R.
Mechanisms of resistance to NTRK inhibitors and therapeutic strategies in NTRK1-rearranged cancers.
Mol. Cancer Ther., 16, 2130-2143 (2017)
Ogura, H., Nagatake-Kobayashi, Y., Adachi, J., Tomonaga, T., Fujita, N. and Katayama, R.
TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity.
Sci. Rep., 7, 5519 (2017)